Cargando…
Fisetin, a 3,7,3′,4′-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models
Psoriasis is a chronic immune-mediated skin disease that involves the interaction of immune and skin cells, and is characterized by cytokine-driven epidermal hyperplasia, deviant differentiation, inflammation, and angiogenesis. Because the available treatments for psoriasis have significant limitati...
Autores principales: | Chamcheu, Jean Christopher, Esnault, Stephane, Adhami, Vaqar M., Noll, Andrea L., Banang-Mbeumi, Sergette, Roy, Tithi, Singh, Sitanshu S., Huang, Shile, Kousoulas, Konstantin G., Mukhtar, Hasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770767/ https://www.ncbi.nlm.nih.gov/pubmed/31540162 http://dx.doi.org/10.3390/cells8091089 |
Ejemplares similares
-
Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation
por: Roy, Tithi, et al.
Publicado: (2023) -
Protective Effect of Fisetin (3,7,3',4'-Tetrahydroxyflavone) against γ-Irradiation-Induced Oxidative Stress and Cell Damage
por: Piao, Mei Jing, et al.
Publicado: (2013) -
Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy
por: Chamcheu, Jean Christopher, et al.
Publicado: (2019) -
Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluation
por: Roy, Tithi, et al.
Publicado: (2021) -
The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
por: Roy, Tithi, et al.
Publicado: (2023)